TPP trade deadlock: Japan leans on US to break impasse
Trans-Pacific Partnership countries oppose US push to set a longer period of exclusivity for pharmaceutical companies who develop biological drugs
Japan called on the US to find a way to break a deadlock over protections for next-generation medicines on Saturday, as talks on a sweeping trade pact were extended for another 24 hours.
Negotiators were up all night trying to broker a deal on the 12-nation Trans-Pacific Partnership, which will create a free trade zone covering 40% of the world economy.
More From Around the Web
Check out these Articles
- Acceliant to Participate in the 4th Annual Clinical Trials Summit in Mumbai
- Iowa Board of Pharmacy Rules Against Medical Marijuana Petition
- Pharmaceutical Drug Analog Screening and Forecasting Online Portal
- US approvals of new medicines reaches new high
- NIBSC and Industry Expert Kevin Ward to Provide Hands on Training for the D...
- GlaxoSmithKline ex-boss to be deported back to UK from China
- Big Pharma Recession Survey Updated for 2013 – Future Trends Predicted
- AM Technical Solutions Acquires Dallas Based Cleanroom Construction Company
- Reducing Risk with Containment of Highly Potent API’s Addressed Later Thi...
- PRS Pharmacy Services Becomes Exclusive Broker for NCPA Members Looking to ...
- NABP Executive Committee Names 2014 Honorary President Gay Dodson, RPh
- PBS Hightens Security in Prescription Blanks
- ALFA to Feature Breakthrough Technology for Rapid Diagnostic Tests at MEDIC...
- Pfizer offers settlement over Parkinson’s drug alleged to have caused...